This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Current Discounted Rates End In:

  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Stefan Nilsson, Ph.D.
CEO at Lipigon Pharmaceuticals AB


Stefan K. Nilsson, PhD, MSc, MBA, is the CEO and founder of Lipigon Pharmaceuticals AB ($LPGO). Nilsson had his training in Prof. Gunilla Olivecrona’s group and earned his PhD 2010 on novel factors affecting triacylglycerol clearance. Nilsson continued as assistant professor and junior group leader at UmU. After a sabbatical year at Hamburg University UKE as guest scientist in Prof. Joerg Heeren’s group he became fulltime CEO at Lipigon 2016. Academic merit includes publications in high ranking journals such as Lancet and Cell Metabolism. Business merit includes successful IPO of Lipigon at Nasdaq First North GM and several research collaboration deals with e.g. AstraZeneca and HitGen Inc.

Agenda Sessions

  • Targeting ANGPTL4 in the Liver with ASO – A Novel Treatment for Cardiometabolic Disease